Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
Objective To review evidence on routinely prescribed drugs in the UK that could upregulate or downregulate ACE2 and potentially affect COVID-19 disease.Design Systematic review.Data source MEDLINE, EMBASE, CINAHL, the Cochrane Library and Web of Science.Study selection Any design with animal or huma...
Saved in:
Main Authors: | Paul Little, Simon J Griffin, Hajira Dambha-Miller, Nazrul Islam, Ali Albasri, Christopher R Wilcox, Sam Hodgson, Shareen Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e040644.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices
by: Paul Little, et al.
Published: (2014-10-01) -
Sleep: An unplayed ace in research and treatment of youth with ACEs
by: Sarah L.H. Kamhout, et al.
Published: (2025-04-01) -
Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation
by: Ayla Valinezhad Orang, et al.
Published: (2014-01-01) -
Interaction mechanism of egg white- derived ACE inhibitory peptide TNGIIR with ACE and its effect on the expression of ACE and AT1 receptor
by: Zhipeng Yu, et al.
Published: (2020-03-01) -
Berberine Protects against Palmitate-Induced Endothelial Dysfunction: Involvements of Upregulation of AMPK and eNOS and Downregulation of NOX4
by: Ming Zhang, et al.
Published: (2013-01-01)